• Data Integrity module

IT Solutions

Data Integrity module

Feb 21 2018

LabWare has developed and launched a new data integrity module for its enterprise LIMS and ELN solution to help drug manufacturers conform to the FDA draft guidance on ‘Data Integrity and Compliance with CGMP’.

The new enhancement to LabWare LIMS & ELN ensures that companies are able to meet current and proposed regulatory guidance regarding the management of data in temporary memory. New and emerging data integrity standards put forth by the U.S. Food and Drug Administration (FDA), U.K. Medicines and Healthcare Products Regulatory Agency (MHRA), and World Health Organization (WHO), which would require the capture of temporary data in electronic records.

The new features are in addition to LabWare current solution that supports a GxP-compliant audit trail based on a full history of analytical testing, including:

Forced Save during manual result entry, to mitigate manipulation of values in temporary memory.

Disabling manual entry when data is captured directly from instrumentation

Forced reviews of Audit Trail entries when exceptions occur, such as result modification

Checksum generation and checking against data records, to detect manipulation.

Date time of data entry

Electronic Signature and mandatory reason for change


Digital Edition

Labmate UK & Ireland 49.2 - March 2024

March 2024

In This Edition Articles - Choosing the right LIMS for your lab: Four key considerations - Pay increases to continue but staff focus on security and training - Building a global culture of...

View all digital editions

Events

Making Pharmaceuticals

Mar 26 2024 Milan, Italy

FORUM LABO LYON

Mar 27 2024 Lyon, France

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

View all events